66th Western Intermountain Neurological Organization (WINO) Conference
66th Western Intermountain Neurological Organization (WINO) Conference
66th WINO Conference
Friday, October 30, 2026
Gregory Wu, MD, PhD
Professor of Neurology
Professor of Pathology and Immunology
Washington University in St. Louis School of Medicine
Dr. Wu completed his internship in medicine at the Mount Sinai School of Medicine and neurology residency at the Hospital of the University of Pennsylvania. He completed his fellowship training in multiple sclerosis at the University of Pennsylvania and a National Multiple Sclerosis Society postdoctoral fellowship in autoimmunity in 2008. In 2008 he was the recipient of a K08 clinical scientist development award from the NINDS for his work investigating the role of dendritic cells in an animal model for MS. That same year he was appointed instructor in the department of Neurology at the University of Pennsylvania. In 2009 Dr. Wu moved to Washington University in St. Louis to establish his own laboratory. During his time at WashU, he has obtained independent funding from the NIH, Doris Duke Charitable Foundation, Dana Foundation, National Multiple Sclerosis Society, and various other private entities. The mission of the Wu lab is to define the mechanisms involved in the regulation of immune responses within the central nervous system. Current work explores how antigen-specific responses targeting the CNS develop and can be abrogated by cellular therapies.
Andrew Mammen, MD, PhD
Muscle Disease Section
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Health
Dr. Andrew Mammen obtained his medical degree and Ph.D. in neuroscience at Johns Hopkins, where he subsequently completed his medicine internship, neurology residency, and neuromuscular fellowship. Upon joining the Hopkins faculty in 2007, he co-founded the Johns Hopkins Myositis Center, where he and his colleagues discovered a novel form of autoimmune myopathy associated with statin use and autoantibodies recognizing HMG-CoA reductase, the pharmacologic target of statins. Dr. Mammen moved to the NIH in 2014, where he is now a Senior Investigator and leads the Muscle Disease Section . His current laboratory and clinical research interests are focused on defining pathogenic mechanisms and potential therapeutic targets in the various forms of autoimmune myopathy.
Parichita Choudhury, MD
Banner Health
Dr. Choudhury earned her medical degree from the University of Alberta, completed residency training in neurology at the University of Calgary, and a fellowship in cognitive and behavioral neurology at the Mayo Clinic. She is a cognitive neurologist and Associate Director of the Memory Clinic at Banner Sun Health Research Institute in Arizona, directs the behavioral neurology fellowship at Banner, as well as the Neuroscience scholar program. She specializes in the diagnosis and management of Alzheimer’s disease, Lewy body dementia, and related neurodegenerative disorders. Dr. Choudhury is actively involved in clinical research focused on improving early and accurate diagnosis of dementia through biomarker development and clinicopathologic correlation. Her work bridges emerging research and practical clinical application to improve outcomes for patients and families living with cognitive disorders.